Nam JS - Search Results

1

Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy.

Hwang JE, Kim SS, Bang HJ, Kim HJ, Shim HJ, Bae WK, Chung IJ, Sun EG, Lee T, Ock CY, Nam JS, Cho SH. Hwang JE, et al. Among authors: nam js. Cancers (Basel). 2024 Sep 30;16(19):3353. doi: 10.3390/cancers16193353. Cancers (Basel). 2024. PMID: 39409972 Free PMC article.

2

Dysadherin awakens mechanical forces and promotes colorectal cancer progression.

Park SY, Lee CJ, Choi JH, Kim JH, Lee WJ, Jang TY, Jeon SE, Kim JH, Cho SH, Lee JS, Nam JS. Park SY, et al. Among authors: nam js. Theranostics. 2022 May 21;12(9):4399-4414. doi: 10.7150/thno.72354. eCollection 2022. Theranostics. 2022. PMID: 35673579 Free PMC article.

3

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer.

Park SY, Choi JH, Nam JS. Park SY, et al. Among authors: nam js. Cancers (Basel). 2019 Jul 9;11(7):965. doi: 10.3390/cancers11070965. Cancers (Basel). 2019. PMID: 31324052 Free PMC article. Review.

4

Machine learning with in silico analysis markedly improves survival prediction modeling in colon cancer patients.

Lee CJ, Baek B, Cho SH, Jang TY, Jeon SE, Lee S, Lee H, Nam JS. Lee CJ, et al. Among authors: nam js. Cancer Med. 2023 Mar;12(6):7603-7615. doi: 10.1002/cam4.5420. Epub 2022 Nov 7. Cancer Med. 2023. PMID: 36345155 Free PMC article.

5

The dysadherin/FAK axis promotes individual cell migration in colon cancer.

Lee CJ, Jang TY, Kim JH, Lim S, Lee S, Nam JS. Lee CJ, et al. Among authors: nam js. Int J Biol Sci. 2024 Apr 8;20(7):2356-2369. doi: 10.7150/ijbs.86699. eCollection 2024. Int J Biol Sci. 2024. PMID: 38725858 Free PMC article.

6

Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells.

Park SY, Kim JY, Jang GB, Choi JH, Kim JH, Lee CJ, Lee S, Baek JH, Park KK, Kim JM, Chang HJ, Cho NC, Nam JS. Park SY, et al. Among authors: nam js. Theranostics. 2021 Aug 11;11(18):8755-8770. doi: 10.7150/thno.63446. eCollection 2021. Theranostics. 2021. PMID: 34522210 Free PMC article.

7

DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.

Kim JH, Park SY, Jeon SE, Choi JH, Lee CJ, Jang TY, Yun HJ, Lee Y, Kim P, Cho SH, Lee JS, Nam JS. Kim JH, et al. Among authors: nam js. Theranostics. 2022 Jul 4;12(12):5258-5271. doi: 10.7150/thno.72037. eCollection 2022. Theranostics. 2022. PMID: 35910805 Free PMC article.

8

TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.

Shin SY, Nam JS, Lim Y, Lee YH. Shin SY, et al. Among authors: nam js. J Biol Chem. 2010 Oct 1;285(40):30731-40. doi: 10.1074/jbc.M110.128124. Epub 2010 Jul 22. J Biol Chem. 2010. PMID: 20650898 Free PMC article.

9

Myricetin induces apoptosis and autophagy in human gastric cancer cells through inhibition of the PI3K/Akt/mTOR pathway.

Han SH, Lee JH, Woo JS, Jung GH, Jung SH, Han EJ, Kim B, Cho SD, Nam JS, Che JH, Jung JY. Han SH, et al. Among authors: nam js. Heliyon. 2022 Apr 22;8(5):e09309. doi: 10.1016/j.heliyon.2022.e09309. eCollection 2022 May. Heliyon. 2022. PMID: 35521506 Free PMC article.

10

Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage.

Park SY, Kim JY, Jun Y, Nam JS. Park SY, et al. Among authors: nam js. Recent Pat Anticancer Drug Discov. 2018;13(1):18-39. doi: 10.2174/1574892812666171003150410. Recent Pat Anticancer Drug Discov. 2018. PMID: 28971778 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters